AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
METHYLPREDNISOLONE SODIUM SUCCINATE
6 registrations across 4 African markets— 3 active
Markets with METHYLPREDNISOLONE SODIUM SUCCINATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Solu-Medrol Powder For Injection | 🇰🇪Kenya | Pfizer Laboratories Limited | active | Mar 2031 |
| Methylprednisolone Sodium Succinate for Injection Powder for injection | 🇳🇬Nigeria | Zadip Healthcare Ltd | active | Aug 2026 |
| NEO-DROL 40MG/VIAL POWDER FOR INJECTION POWDER FOR INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| SOLU-MEDROL 40MG/ML STERILE POWDER + DILUENT FOR INJECTION STERILE POWDER + DILUENT FOR INJECTION | 🇲🇼Malawi | — | expired | Jun 2004 |
| SOLU-MEDROL 40MG STERILE POWDER + DILUENT FOR INJECTION STERILE POWDER + DILUENT FOR INJECTION | 🇲🇼Malawi | — | expired | Jun 2003 |
| PDSOLONE-40 Powder for Injection | 🇹🇿Tanzania | Swiss Parenterals Limited | active | — |
METHYLPREDNISOLONE SODIUM SUCCINATE in Africa — Regulatory Overview
METHYLPREDNISOLONE SODIUM SUCCINATE is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Kenya, Nigeria, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 3 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.